Costalos C, Gounaris A, Sevastiadou S, Hatzistamatiou Z, Theodoraki M, Alexiou E N, Constandellou E
Department of Neonatal Medicine, Alexandra General Hospital Athens, Greece.
Early Hum Dev. 2003 Nov;74(2):83-8. doi: 10.1016/s0378-3782(03)00087-2.
Postnatal glucocorticosteroid administration has trophic effects on the gastrointestinal tract of preterm infants. The aim of the present study was to investigate whether antenatal glucocorticosteroids affect the secretion of gastrointestinal peptides that are involved in the regulation of secretion, motility and mucosal protection of the gastrointestinal tract.
Plasma levels of gastrin, motilin and vasoactive intestinal peptide (VIP) were estimated in 28 preterm infants with a mean birth weight of 1280 g, and mean gestational age of 30.5 weeks, whose mothers had received a full course of antenatal glucocorticosteroids (GC group) and in 17 preterm infants with mean birth weight of 1200 g, mean gestational age of 30.2 weeks, whose mothers had not received corticosteroids (control group). GI peptides were estimated on two occasions: (a) Immediately after birth and (b) following the initiation of enteral feeding.
Gastrin levels in the GC group were significantly higher both immediately after birth (early measurement) and also after receiving enteral feeding (late measurement) (p<0.001, p<0.05, respectively) but the increase in plasma gastrin concentration was identical in both groups (32 vs. 33 pg/ml). Motilin levels in the GC group were also significantly higher as compared to the control group but only in the late measurement (p<0.001). Gastrin and motilin levels in both groups were significantly higher in the late measurement as compared to the early measurement (GC group: p<0.001, p<0.001, respectively;
p<0.001, p<0.01, respectively). There was no significant difference in VIP levels between the two groups both in the early and the late measurements.
Antenatal glucocorticoids (GCs) stimulate gastrin secretion in the fetus but not in the neonate. Contrary to this, corticosteroid effect on motilin is seen only postnatally following the introduction of enteral feeding. Glucocorticosteroids appear to have no effect on VIP levels. Plasma gastrin and motilin levels increase significantly following the introduction of enteral feeding regardless of the use of steroids.
产后给予糖皮质激素对早产儿胃肠道有营养作用。本研究的目的是调查产前糖皮质激素是否会影响参与胃肠道分泌、运动和黏膜保护调节的胃肠道肽的分泌。
对28名平均出生体重1280克、平均胎龄30.5周的早产儿进行胃泌素、胃动素和血管活性肠肽(VIP)血浆水平评估,这些早产儿的母亲接受了完整疗程的产前糖皮质激素治疗(糖皮质激素组);同时对17名平均出生体重1200克、平均胎龄30.2周的早产儿进行评估,这些早产儿的母亲未接受糖皮质激素治疗(对照组)。在两个时间点评估胃肠道肽:(a)出生后立即评估;(b)开始肠内喂养后评估。
糖皮质激素组出生后立即(早期测量)和接受肠内喂养后(晚期测量)胃泌素水平均显著更高(分别为p<0.001,p<0.05),但两组血浆胃泌素浓度的升高幅度相同(32对33 pg/ml)。糖皮质激素组的胃动素水平与对照组相比也显著更高,但仅在晚期测量时(p<0.001)。两组的胃泌素和胃动素水平在晚期测量时均显著高于早期测量(糖皮质激素组:分别为p<0.001,p<0.001;对照组:分别为p<0.001,p<0.01)。两组在早期和晚期测量时VIP水平均无显著差异。
产前糖皮质激素(GCs)刺激胎儿而非新生儿的胃泌素分泌。与此相反,糖皮质激素对胃动素的作用仅在出生后引入肠内喂养后才可见。糖皮质激素似乎对VIP水平无影响。无论是否使用类固醇,引入肠内喂养后血浆胃泌素和胃动素水平均显著升高。